Medical Technology company Inogen Inc (NASDAQ:INGN) reported a fourth-quarter adjusted EPS loss of 24 cents, compared to a loss of 83 cents a year ago, beating the consensus loss of 61 cents. The ...
Inogen’s share price has performed poorly since I rated the stock a Buy in July 2023, and for good reason. Another round of senior executive changes combined with a questionable acquisition has ...
Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter and the full year ended December ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results